Psoriasis is a common chronic inflammatory condition of the skin, which also has nails and systemic involvement. Psoriatic involvement of the nail bed or nail matrix results in nail psoriasis. Nail involvement is a visible indicator to predict future joint inflammatory damages and disease activity. Nail psoriasis can manifest clinically as a wide variety of nail changes, like nail discoloration, subungual hyperkeratosis, pitting and onycholysis, depending upon the part of the nail units affected. Patients with psoriatic nails have impaired quality of life due to the appearance of nails, and significant morbidity and functional impairments may arise in large cases. Its management is challenging because it is long term, and often not satisfying the patients leads to depression, which further deteriorates the condition. Patient education with explaining the prognosis and outcomes of the treatment is the most important aspect.
The exact etiology of nail psoriasis is unclear, but multiple factors may contribute to being the etiology of nail psoriasis, which include genetic, immunological, and environmental factors. However, dysregulation of innate immunity is thought to be the stronger associated factor, while genetic factors are not well understood. Family history is common, and human leukocyte antigens (Cw6, B13, B17) are associated with it.
Nail psoriasis affects both children and adults. It equally affects males and females and has increase prevalence with increasing age. Nail Psoriasis mostly develops in association with cutaneous psoriasis and psoriatic arthritis with a prevalence of 10% to 55% and 80% to 90%, respectively. Nail psoriasis may develop as a sole manifestation. The involvement of nail in a patient with cutaneous psoriasis is concurrent or develops after the onset of cutaneous symptoms.
Nail psoriasis usually results from psoriatic inflammation involving the nail bed or nail matrix. The matrix of the nail is mainly responsible for nail plate formation and is located beneath the proximal nail fold. The superficial part of the nail plate is formed from the proximal nail matrix while the deep part is formed from the distal nail matrix. The nail bed lies directly beneath the nail plate and plays a significant role in the adherence of the nail plate to the nail bed. Clinical features related to nail matrix involvement are nail Pitting, red spots in the lunula, leukonychia, and crumbling of the complete nail plate. The involvement of the nail bed manifests clinically as Onycholysis, splinter hemorrhages, subungual hyperkeratosis, and oil drop discoloration.
Genetic contributions to the formation of nail psoriasis are still uncertain. Psoriatic nail disease may, however, align more closely with innate immunity dysregulation. Thus, psoriatic nail disease can contribute differently to innate and adaptive immunity than the disease limited to the skin.
Histopathological findings of nail psoriasis are similar to cutaneous psoriasis, and it includes mild to moderate hyperkeratosis, spongiosis, and focal hyperkeratosis. Other prominent features are neutrophilic inflammatory infiltrate, hypergranulosis, and papillomatous epidermal hyperplasia. Papillary dermis shows dilated tortuous inflamed capillaries. The hyponychium shows the loss of the granular layer while there is hypergranulosis in the nail bed and matrix of the nail.
As nail psoriasis is strongly associated with cutaneous psoriasis and psoriatic arthritis, one should take the proper history of the skin lesions and joint-related symptoms like swelling and pain. Most of the patients with psoriatic arthritis present with involvement of distal interphalangeal joints. Presentation of nail psoriasis alone without any cutaneous and joint involvement is always a diagnostic challenge in many cases.
A patient of nail psoriasis may have either one or multiple affected finger and toenails. The psoriatic nail may have more than one clinical manifestation in a single nail depending upon the part of the nail apparatus affected. The common clinical manifestations of nail psoriasis are nail Pitting, subungual hyperkeratosis, onycholysis, and oil drop discoloration. However, nail plate crumbling, red spots in lunula, leuconychia, and splinter hemorrhages are other features. Patients may have manifestations like onychorrhexis and beau lines, which are longitudinal ridges with distal nail plate splitting and transverse grooves, respectively.
A complete thorough examination of the skin, including the scalp and anogenital area, is important to assess the extent and severity of the condition. Nail psoriasis is a common feature of patients presenting with psoriatic arthritis, and it is prudent to assess signs of psoriatic arthritis. Examine for the swelling and tenderness of the joints, especially distal interphalangeal joints of both feet and hands and swelling of digits.
Nail psoriasis is usually diagnosed on a clinical basis by a proper history and complete physical examination. Fungal infection testing is also necessary in few cases to rule out onychomycosis. The biopsy is not necessary except for selective cases where the diagnosis is uncertain, and biopsy of the nail bed or nail matrix is taken and sent for histological examination.
Patient with nail psoriasis is treated with either topical or systemic therapy. Other options include biologic agents, photodynamic therapy, phototherapy, intense pulsed light, and lasers treatment. The treatment options mainly depend upon the severity and extent of disease. The various other factors which need to be considered for treatment options are the age of the patient, comorbidities, profession, concomitant skin and joint involvement, impact on the quality of life, patient preference, and cost of treatment.
Mild nail psoriasis:
Moderate to severe nail psoriasis:
This therapy is very effective, but few patients don’t prefer this option due to cost and affordability issues. These biological agents increase the risk of fungal skin infections.
Additional therapies need further recommendations to include oral tofacitinib, topical cyclosporine, topical indigo naturalist, oral acitretin, oral cyclosporine, and phototherapy.
Patients with nail psoriasis have a chronic and protracted course with periods of improvement and worsening with a greatly profound effect on the quality of life.patient may have periods of normal nails without alteration.patients of psoriasis with nail involvement have a poor prognosis. nail trauma may be the trigger and exacerbating factor for nail psoriasis.treatment with topical agents in case of mild disease and systemic therapy in moderate to severe disease may alter the disease process in the long run but on the cost of side effects and complications.
The patient suffering from nail psoriasis may develop complications either due to the disease process itself or as a result of drugs used in treatment. The major complications can be grouped into functional disability, psychological distress, and infections, including bacterial and fungal infections.acute and chronic paronychia and onychomycosis.
Nail psoriasis is a chronic disease process, treatment may be prolonged, and education of patients is an essential part of management. The treatment is prolonged due to a slow nail growth pace, which leads to a prolonged course of treatment. Proper communication with the patient may encourage reasonable perceptions of treatment outcomes, and it may facilitate therapy adherence. Patients need to follow gentle hand and foot care measures that may help to decrease the symptoms. These general measures include the regular application of emollients, regularly trimming of the nails, keep them dry and protection from trauma to prevent Koebner phenomena. In addition, they need to take photographs of nails periodically as these pictures would help to assess the treatment response.
Nail psoriasis is a difficult condition to manage, and its management is best by an interprofessional team.
Even though sometimes primary clinicians manage these patients, it is best to refer these patients to the dermatologist. Dermatology specialty-trained nurses can also help by counseling the patient, providing direction on medical management, and monitoring and charting treatment progress. A pharmacist should also be on the case, with assistance in selecting the most appropriate agents, verifying dosing, offering patient education, and performing medication reconciliation, informing the prescriber of any issues encountered. Close communication between interprofessional team members is vital to achieving desired outcomes.
|||Jendoubi F,Ben Lagha I,Rabhi F,Doss N,Mrabet A,Jaber K,Dhaoui MR, Nail Involvement in Psoriatic Patients and Association with Onychomycosis: Results from a Cross-Sectional Study Performed in a Military Hospital in Tunisia. Skin appendage disorders. 2019 Aug; [PubMed PMID: 31559254]|
|||Egeberg A,See K,Garrelts A,Burge R, Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort. BMC dermatology. 2020 May 20; [PubMed PMID: 32434510]|
|||Pouw JN,Leijten EFA,Tekstra J,Balak DMW,Radstake TRDJ, [Spectrum of psoriatic conditions]. Nederlands tijdschrift voor geneeskunde. 2019 Jul 29; [PubMed PMID: 31361418]|
|||Wanniang N,Navya A,Pai V,Ghodge R, Comparative Study of Clinical and Dermoscopic Features in Nail Psoriasis. Indian dermatology online journal. 2020 Jan-Feb; [PubMed PMID: 32055506]|
|||Dopytalska K,Sobolewski P,Błaszczak A,Szymańska E,Walecka I, Psoriasis in special localizations. Reumatologia. 2018; [PubMed PMID: 30647487]|
|||Rusk AM,Fleischer AB Jr, In psoriasis treatment, greater improvement in skin severity predicts greater improvement in nail severity. The Journal of dermatological treatment. 2020 Feb 5; [PubMed PMID: 31971034]|
|||Kaya İslamoğlu ZG,Uysal E,Demirbaş A,İslamoğlu N, Evaluating nail thickness and stiffness with shear-wave elastography in nail psoriasis: A preliminary study. Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI). 2020 Jan; [PubMed PMID: 31338888]|
|||Lanna C,Galluzzi C,Zangrilli A,Bavetta M,Bianchi L,Campione E, Psoriasis in difficult to treat areas: treatment role in improving health-related quality of life and perception of the disease stigma. The Journal of dermatological treatment. 2020 May 18; [PubMed PMID: 32419527]|
|||Tada Y,Ishii K,Kimura J,Hanada K,Kawaguchi I, Patient preference for biologic treatments of psoriasis in Japan. The Journal of dermatology. 2019 Jun; [PubMed PMID: 30985030]|
|||Lanna C,Zangrilli A,Bavetta M,Campione E,Bianchi L, Efficacy and safety of adalimumab in difficult-to-treat psoriasis. Dermatologic therapy. 2020 Apr 3; [PubMed PMID: 32246516]|
|||Rigopoulos D,Baran R,Chiheb S,Daniel CR 3rd,Di Chiacchio N,Gregoriou S,Grover C,Haneke E,Iorizzo M,Pasch M,Piraccini BM,Rich P,Richert B,Rompoti N,Rubin AI,Singal A,Starace M,Tosti A,Triantafyllopoulou I,Zaiac M, Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: A dermatologist and nail expert group consensus. Journal of the American Academy of Dermatology. 2019 Jul; [PubMed PMID: 30731172]|
|||Krajewska-Włodarczyk M,Owczarczyk-Saczonek A,Placek W,Wojtkiewicz M,Wojtkiewicz J, Effect of Methotrexate in the Treatment of Distal Interphalangeal Joint Extensor Tendon Enthesopathy in Patients with Nail Psoriasis. Journal of clinical medicine. 2018 Dec 14; [PubMed PMID: 30558114]|
|||Baran R, [How to diagnose and treat psoriasis of the nails]. Presse medicale (Paris, France : 1983). 2014 Nov; [PubMed PMID: 25443636]|
|||Moreno-Romero JA,Grimalt R, Nail Pitting in Psoriasis. The New England journal of medicine. 2018 Nov 29; [PubMed PMID: 30485773]|